Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Onconetix (ONCO) Operating Expenses (2023 - 2025)

Historic Operating Expenses for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $2.3 million.

  • Onconetix's Operating Expenses fell 1501.65% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.8 million, marking a year-over-year decrease of 389.02%. This contributed to the annual value of $57.5 million for FY2024, which is 6484.7% up from last year.
  • As of Q3 2025, Onconetix's Operating Expenses stood at $2.3 million, which was down 1501.65% from $2.0 million recorded in Q2 2025.
  • Onconetix's 5-year Operating Expenses high stood at $29.8 million for Q4 2024, and its period low was $2.0 million during Q2 2025.
  • Over the past 3 years, Onconetix's median Operating Expenses value was $6.6 million (recorded in 2023), while the average stood at $9.9 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first soared by 29571.51% in 2024, then plummeted by 8537.5% in 2025.
  • Onconetix's Operating Expenses (Quarter) stood at $20.9 million in 2023, then soared by 42.47% to $29.8 million in 2024, then crashed by 92.16% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, $2.0 million for Q2 2025, and $12.6 million during Q1 2025.